• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Proteins as possible targets for cytotoxic trans-platinum(II) complexes with aliphatic amine ligands: Further exceptions to the DNA paradigm.蛋白可能成为带有脂肪族胺配体的细胞毒性反式铂(II)配合物的作用靶点:对 DNA 范例的进一步修正。
ChemMedChem. 2010 Aug 2;5(8):1335-43. doi: 10.1002/cmdc.201000104.
2
Modulation of drug activation profiles through carboxylate ligand modification in cytotoxic trans-platinum planar amine compounds.通过细胞毒性反式铂平面胺化合物中羧酸配体的修饰来调节药物激活特性。
Dalton Trans. 2011 Nov 7;40(41):10983-8. doi: 10.1039/c1dt10964b. Epub 2011 Sep 14.
3
Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.两种带有脂肪族胺配体的细胞毒性反式铂(II)配合物的溶液行为和生物分子相互作用
Chemistry. 2009 Sep 14;15(36):9139-46. doi: 10.1002/chem.200901090.
4
The preparation and characterization of trans-platinum(IV) complexes with unusually high cytotoxicity.具有异常高细胞毒性的反式铂(IV)配合物的制备与表征。
Dalton Trans. 2011 Jan 14;40(2):344-7. doi: 10.1039/c0dt00565g. Epub 2010 Oct 8.
5
Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.在含有双齿氮、氧供体吡啶-2-基乙酸酯的结构新颖的铂(II)配合物中,细胞毒性的顺式几何要求发生了反转。
Inorg Chem. 2000 May 1;39(9):1882-90. doi: 10.1021/ic991259p.
6
Studying the interactions of a platinum(II) 9-aminoacridine complex with proteins and oligonucleotides by ESI-TOF MS.通过电喷雾飞行时间质谱研究铂(II)9-氨基吖啶配合物与蛋白质和寡核苷酸的相互作用。
Dalton Trans. 2012 Jan 7;41(1):300-6. doi: 10.1039/c1dt11506e. Epub 2011 Nov 17.
7
Characterization of Pt-protein complexes by nHPLC-ESI-LTQ MS/MS using a gel-based bottom-up approach.采用基于凝胶的自上而下方法,通过 nHPLC-ESI-LTQ MS/MS 对 Pt 蛋白复合物进行表征。
Talanta. 2012 Jan 15;88:599-608. doi: 10.1016/j.talanta.2011.11.044. Epub 2011 Nov 19.
8
Elucidating the reactivity of Pt(II) complexes with (O,S) bidentate ligands towards DNA model systems.阐明Pt(II)配合物与(O,S)双齿配体对DNA模型系统的反应活性。
J Inorg Biochem. 2016 Jul;160:198-209. doi: 10.1016/j.jinorgbio.2016.02.013. Epub 2016 Feb 12.
9
The second generation of iodido complexes: trans-[PtI2(amine)(amine')] bearing different aliphatic amines.第二代碘配合物:[PtI2(胺)(胺')]顺式异构体,具有不同的脂肪族胺。
J Inorg Biochem. 2013 Oct;127:182-7. doi: 10.1016/j.jinorgbio.2013.04.010. Epub 2013 Apr 28.
10
Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands.锌7金属硫蛋白与顺式和反式-[Pt(N-供体)₂Cl₂]抗癌配合物的反应:反式Pt(II)配合物保留其N-供体配体。
J Med Chem. 2007 Aug 23;50(17):4075-86. doi: 10.1021/jm070271l. Epub 2007 Aug 1.

引用本文的文献

1
Simultaneous mass spectrometry analysis of cisplatin with oligonucleotide-peptide mixtures: implications for the mechanism of action.顺铂与寡核苷酸-肽混合物的同时质谱分析:对作用机制的启示。
J Biol Inorg Chem. 2022 Mar;27(2):239-248. doi: 10.1007/s00775-022-01924-9. Epub 2022 Jan 22.
2
Mass spectrometry-guided optimization and characterization of a biologically active transferrin-lysozyme model drug conjugate.基于质谱的生物活性转铁蛋白-溶菌酶模型药物偶联物的优化和表征。
Mol Pharm. 2013 May 6;10(5):1998-2007. doi: 10.1021/mp400026y. Epub 2013 Apr 10.
3
Platinum-based drugs and proteins: reactivity and relevance to DNA adduct formation.铂类药物和蛋白质:与 DNA 加合物形成的反应性和相关性。
J Inorg Biochem. 2013 May;122:27-37. doi: 10.1016/j.jinorgbio.2013.01.007. Epub 2013 Jan 23.
4
Organometallic Palladium Complexes with a Water-Soluble Iminophosphorane Ligand as Potential Anticancer Agents.具有水溶性亚氨基膦烷配体的有机金属钯配合物作为潜在的抗癌剂
Organometallics. 2012 Aug 27;31(16):5772-5781. doi: 10.1021/om3006239. Epub 2012 Jul 25.

本文引用的文献

1
Tandem mass spectrometry of small, multiply charged oligonucleotides.串联质谱法分析小的、多电荷寡核苷酸。
J Am Soc Mass Spectrom. 1992 Jan;3(1):60-70. doi: 10.1016/1044-0305(92)85019-G.
2
Reactivity of anticancer metallodrugs with serum proteins: new insights from size exclusion chromatography-ICP-MS and ESI-MS.抗癌金属药物与血清蛋白的反应性:尺寸排阻色谱-电感耦合等离子体质谱和电喷雾电离质谱的新见解
J Anal At Spectrom. 2010 Mar;25(3):305-313. doi: 10.1039/B922701F.
3
Ruthenium versus platinum: interactions of anticancer metallodrugs with duplex oligonucleotides characterised by electrospray ionisation mass spectrometry.钌与铂:电喷雾电离质谱法研究抗癌金属药物与双链寡核苷酸的相互作用。
J Biol Inorg Chem. 2010 Jun;15(5):677-88. doi: 10.1007/s00775-010-0635-0. Epub 2010 Mar 7.
4
The mechanism of action of platinum anticancer agents--what do we really know about it?铂类抗癌药物的作用机制——我们真的了解多少?
Dalton Trans. 2009 Dec 28(48):10681-9. doi: 10.1039/b918871c. Epub 2009 Oct 20.
5
Methionine can favor DNA platination by trans-coordinated platinum antitumor drugs.甲硫氨酸可通过反式配位的铂类抗肿瘤药物促进DNA铂化。
Angew Chem Int Ed Engl. 2009;48(45):8497-500. doi: 10.1002/anie.200902948.
6
Platinum drug distribution in cancer cells and tumors.铂类药物在癌细胞和肿瘤中的分布。
Chem Rev. 2009 Oct;109(10):4911-20. doi: 10.1021/cr9001066.
7
Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.两种带有脂肪族胺配体的细胞毒性反式铂(II)配合物的溶液行为和生物分子相互作用
Chemistry. 2009 Sep 14;15(36):9139-46. doi: 10.1002/chem.200901090.
8
Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes.胺配体对反式二胺铂(II)抗癌配合物的水合作用及细胞毒性的影响。
Dalton Trans. 2009 May 14(18):3457-66. doi: 10.1039/b819301k. Epub 2009 Jan 29.
9
The influence of Cisplatin on the gas-phase dissociation of oligonucleotides studied by electrospray ionization tandem mass spectrometry.顺铂对通过电喷雾电离串联质谱法研究的寡核苷酸气相解离的影响。
J Am Soc Mass Spectrom. 2009 May;20(5):792-804. doi: 10.1016/j.jasms.2008.12.018. Epub 2008 Dec 31.
10
High resolution mass spectrometry for studying the interactions of cisplatin with oligonucleotides.用于研究顺铂与寡核苷酸相互作用的高分辨率质谱法。
Inorg Chem. 2008 Nov 17;47(22):10626-33. doi: 10.1021/ic801371r. Epub 2008 Oct 24.

蛋白可能成为带有脂肪族胺配体的细胞毒性反式铂(II)配合物的作用靶点:对 DNA 范例的进一步修正。

Proteins as possible targets for cytotoxic trans-platinum(II) complexes with aliphatic amine ligands: Further exceptions to the DNA paradigm.

机构信息

Departamento de Química Inorgánica, Universidad Autónoma de Madrid, Spain.

出版信息

ChemMedChem. 2010 Aug 2;5(8):1335-43. doi: 10.1002/cmdc.201000104.

DOI:10.1002/cmdc.201000104
PMID:20564276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3920175/
Abstract

The reactivity of three cytotoxic trans-Pt(II) complexes bearing aliphatic amine ligands, with transferrin and single-stranded oligonucleotides as DNA models, was investigated by ESI-MS and the results obtained are discussed in comparison with cisplatin. Tandem MS studies provided additional information on the preferential Pt binding sites. To determine whether trans-Pt(II) complexes can migrate from a peptide to an oligonucleotide, transfer experiments were also performed using ESI-MS, and competitive binding of the trans-Pt(II) complexes toward a model peptide and different oligonucleotides was also investigated. Significant differences in the reactivity of the trans complexes with respect to cisplatin were observed. In general, adduct formation with the selected peptide is favored for the trans compounds, whereas cisplatin shows a preference for oligonucleotides, especially if adjacent G-G residues are present. The results are discussed in relation to the possible mechanism of action of the trans-Pt(II) complexes.

摘要

研究了三种带有脂肪胺配体的细胞毒性反式-Pt(II)配合物与转铁蛋白和单链寡核苷酸作为 DNA 模型的反应活性,通过 ESI-MS 进行了研究,并将结果与顺铂进行了比较。串联 MS 研究提供了关于优先 Pt 结合位点的附加信息。为了确定反式-Pt(II)配合物是否可以从肽转移到寡核苷酸,还使用 ESI-MS 进行了转移实验,并研究了反式-Pt(II)配合物对模型肽和不同寡核苷酸的竞争结合。观察到反式配合物与顺铂的反应活性有显著差异。一般来说,与所选肽的加合物形成有利于反式化合物,而顺铂则优先与寡核苷酸结合,特别是如果存在相邻的 G-G 残基。结果与反式-Pt(II)配合物的可能作用机制有关。